APA

Epstein J. E., Charoenvit Y., Kester K. E., Wang R., Newcomer R., Fitzpatrick S., Richie T. L., Tornieporth N., Heppner D. G., Ockenhouse C., Majam V., Holland C., Abot E., Ganeshan H., Berzins M., Jones T., Freydberg C. N., Ng J., Norman J., Carucci D. J., Cohen J. & Hoffman S. L. (20040720). Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. : Vaccine.

Chicago

Epstein Judith E, Charoenvit Yupin, Kester Kent E, Wang Ruobing, Newcomer Rhonda, Fitzpatrick Steve, Richie Thomas L, Tornieporth Nadia, Heppner D Gray, Ockenhouse Chris, Majam Victoria, Holland Carolyn, Abot Esteban, Ganeshan Harini, Berzins Mara, Jones Trevor, Freydberg C Nicole, Ng Jennifer, Norman Jon, Carucci Daniel J, Cohen Joe and Hoffman Stephen L. 20040720. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. : Vaccine.

Harvard

Epstein J. E., Charoenvit Y., Kester K. E., Wang R., Newcomer R., Fitzpatrick S., Richie T. L., Tornieporth N., Heppner D. G., Ockenhouse C., Majam V., Holland C., Abot E., Ganeshan H., Berzins M., Jones T., Freydberg C. N., Ng J., Norman J., Carucci D. J., Cohen J. and Hoffman S. L. (20040720). Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. : Vaccine.

MLA

Epstein Judith E, Charoenvit Yupin, Kester Kent E, Wang Ruobing, Newcomer Rhonda, Fitzpatrick Steve, Richie Thomas L, Tornieporth Nadia, Heppner D Gray, Ockenhouse Chris, Majam Victoria, Holland Carolyn, Abot Esteban, Ganeshan Harini, Berzins Mara, Jones Trevor, Freydberg C Nicole, Ng Jennifer, Norman Jon, Carucci Daniel J, Cohen Joe and Hoffman Stephen L. Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A. : Vaccine. 20040720.